Protective Function of Mitogen-Activated Protein Kinase Phosphatase 5 in Aging- and Diet-Induced Hepatic Steatosis and Steatohepatitis.


Journal

Hepatology communications
ISSN: 2471-254X
Titre abrégé: Hepatol Commun
Pays: United States
ID NLM: 101695860

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 30 08 2018
accepted: 19 01 2019
entrez: 7 6 2019
pubmed: 7 6 2019
medline: 7 6 2019
Statut: epublish

Résumé

Nonalcoholic fatty liver disease is currently the most common liver disease and is a leading cause of liver-related morbidity and mortality. However, its pathogenesis remains largely unclear. We previously showed that mice deficient in mitogen-activated protein kinase (MAPK) phosphatase 5 (MKP5) spontaneously developed insulin resistance and glucose intolerance, which are associated with visceral obesity and adipose tissue inflammation. In this study, we discovered that mice deficient in MKP5 developed more severe hepatic steatosis and steatohepatitis with age or with feeding on a high-fat diet (HFD) compared to wild-type (WT) mice, and this was associated with increased expression of proinflammatory cytokines and collagen genes. Increased p38 activation in MKP5 knockout (KO) liver compared to that in WT liver was detected, which contributed to increased expression of lipid droplet-associated protein cell death-inducing DFF45-like effector A (CIDEA) and CIDEC/fat-specific protein 27 but not CIDEB through activating transcription factor 2 (ATF2). In addition, MKP5 KO liver had higher peroxisome proliferator-activated receptor gamma (PPARγ) expression compared with WT liver. On the other hand, overexpression of MKP5 or inhibition of p38 activation in hepatocytes resulted in reduced expression of PPARγ. Inhibition of p38 resulted in alleviation of hepatic steatosis in KO liver in response to HFD feeding, and this was associated with reduced expression of CIDEA, CIDEC, and proinflammatory cytokines.

Identifiants

pubmed: 31168510
doi: 10.1002/hep4.1324
pii: HEP41324
pmc: PMC6546013
doi:

Types de publication

Journal Article

Langues

eng

Pagination

748-762

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

J Clin Invest. 2003 Mar;111(5):737-47
pubmed: 12618528
Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1676-81
pubmed: 15242861
J Clin Invest. 2005 May;115(5):1139-42
pubmed: 15864343
Biochem Biophys Res Commun. 2005 Oct 14;336(1):215-22
pubmed: 16125673
Mol Cell Biol. 2006 Feb;26(3):1063-76
pubmed: 16428458
Cell Metab. 2006 Jul;4(1):61-73
pubmed: 16814733
J Biol Chem. 2007 Feb 16;282(7):4975-82
pubmed: 17172644
J Biol Chem. 2007 Jun 22;282(25):18613-24
pubmed: 17462989
Nat Genet. 2007 Jun;39(6):741-9
pubmed: 17468757
Hepatology. 2007 Aug;46(2):414-23
pubmed: 17654601
Cell Mol Life Sci. 2007 Nov;64(21):2771-89
pubmed: 17726577
Cell Metab. 2008 Apr;7(4):302-11
pubmed: 18396136
Annu Rev Biochem. 2008;77:289-312
pubmed: 18518822
Cancer Cell. 2008 Aug 12;14(2):156-65
pubmed: 18691550
Biochem J. 2010 Aug 1;429(3):403-17
pubmed: 20626350
Hepatology. 2010 Dec;52(6):2001-11
pubmed: 20938947
J Clin Endocrinol Metab. 2011 May;96(5):1424-30
pubmed: 21325464
J Nutr. 2011 Apr 1;141(4):603-10
pubmed: 21346097
FASEB J. 2011 Aug;25(8):2538-50
pubmed: 21507897
J Physiol Biochem. 2011 Dec;67(4):629-36
pubmed: 21847662
Hepatology. 2012 Jul;56(1):95-107
pubmed: 22278400
Arterioscler Thromb Vasc Biol. 2012 May;32(5):1094-8
pubmed: 22517368
Cancer Res. 2013 Jan 1;73(1):215-24
pubmed: 23271722
Hepatology. 2013 May;57(5):1950-61
pubmed: 23354775
Diabetes. 2014 Sep;63(9):2924-34
pubmed: 24722245
Hepatology. 2015 Mar;61(3):857-69
pubmed: 25125366
Hepatology. 2015 Mar;61(3):870-82
pubmed: 25179419
Hepatology. 2015 Sep;62(3):964-7
pubmed: 25854913
J Immunol. 2015 May 15;194(10):4759-66
pubmed: 25888643
J Hepatol. 2015 Apr;62(1 Suppl):S47-64
pubmed: 25920090
J Biol Chem. 2015 Jun 12;290(24):14875-83
pubmed: 25922079
Int J Clin Exp Pathol. 2015 Aug 01;8(8):8699-708
pubmed: 26464614
Exp Cell Res. 2016 Jan 15;340(2):187-92
pubmed: 26515554
Hepatology. 2019 Jan;69(1):76-93
pubmed: 30063256

Auteurs

Peng Tang (P)

Department of Microbiology and Immunology Yong Loo Lin School of Medicine, National University of Singapore Singapore.
Immunology Program, Life Sciences Institute National University of Singapore Singapore.

Heng Boon Low (HB)

Department of Microbiology and Immunology Yong Loo Lin School of Medicine, National University of Singapore Singapore.
Immunology Program, Life Sciences Institute National University of Singapore Singapore.

Chin Wen Png (CW)

Department of Microbiology and Immunology Yong Loo Lin School of Medicine, National University of Singapore Singapore.
Immunology Program, Life Sciences Institute National University of Singapore Singapore.

Federico Torta (F)

Department of Biochemistry Yong Loo Lin School of Medicine, National University of Singapore Singapore.
Singapore Lipidomics Incubator, Life Sciences Institute National University of Singapore Singapore.

Jaspal Kaur Kumar (JK)

Singapore Lipidomics Incubator, Life Sciences Institute National University of Singapore Singapore.

Hwee Ying Lim (HY)

Department of Microbiology and Immunology Yong Loo Lin School of Medicine, National University of Singapore Singapore.
Immunology Program, Life Sciences Institute National University of Singapore Singapore.

Yi Zhou (Y)

Cancer Science Institute of Singapore Yong Loo Lin School of Medicine, National University of Singapore Singapore.

Henry Yang (H)

Cancer Science Institute of Singapore Yong Loo Lin School of Medicine, National University of Singapore Singapore.

Veronique Angeli (V)

Department of Microbiology and Immunology Yong Loo Lin School of Medicine, National University of Singapore Singapore.
Immunology Program, Life Sciences Institute National University of Singapore Singapore.

Asim Shabbir (A)

Department of Medicine Yong Loo Lin School of Medicine, National University of Singapore Singapore.

E Shyong Tai (ES)

Department of Medicine Yong Loo Lin School of Medicine, National University of Singapore Singapore.

Richard A Flavell (RA)

Department of Immunobiology Howard Hughes Medical Institute, Yale University New Haven CT.

Chen Dong (C)

Tsinghua University Beijing China.

Markus R Wenk (MR)

Department of Biochemistry Yong Loo Lin School of Medicine, National University of Singapore Singapore.
Singapore Lipidomics Incubator, Life Sciences Institute National University of Singapore Singapore.

Dan Yock Yang (DY)

Department of Medicine Yong Loo Lin School of Medicine, National University of Singapore Singapore.

Yongliang Zhang (Y)

Department of Microbiology and Immunology Yong Loo Lin School of Medicine, National University of Singapore Singapore.
Immunology Program, Life Sciences Institute National University of Singapore Singapore.

Classifications MeSH